Vertex Income Statement Research

VRTX Stock

USD 404.91 4.99 1.25%

Most accounts from Vertex Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Vertex Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Vertex Pharmaceuticals Valuation and Vertex Pharmaceuticals Correlation analysis.

For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.

At this time, Vertex Pharmaceuticals' Cost Of Revenue is fairly stable compared to the past year. Income Before Tax is likely to rise to about 4.6 B in 2024, whereas Interest Expense is likely to drop slightly above 28.9 M in 2024.

For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.At this time, Vertex Pharmaceuticals' Cost Of Revenue is fairly stable compared to the past year. Income Before Tax is likely to rise to about 4.6 B in 2024, whereas Interest Expense is likely to drop slightly above 28.9 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	6.7B	7.9B	8.6B	9.0B
Total Revenue	7.6B	8.9B	9.8B	10.3B

Gross Profit Total Revenue

Vertex Pharmaceuticals income statement Correlations

	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Total Operating Expenses	Net Income	Income Tax Expense	Depreciation And Amortization	Cost Of Revenue	Income Before Tax	Total Other Income Expense Net	Research Development	Interest Expense	Selling General Administrative	Extraordinary Items	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Discontinued Operations	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation
Total Revenue		1.0	0.98	0.97	0.97	0.97	0.97	0.96	0.64	0.45	1.0	0.98	0.63	0.97	0.05	0.97	0.45	0.96	-0.04	0.14	0.65	0.61	0.66	0.79	0.94
Gross Profit	1.0		0.98	0.97	0.98	0.98	0.97	0.95	0.64	0.45	0.99	0.98	0.63	0.96	0.06	0.97	0.45	0.96	-0.04	0.14	0.64	0.62	0.65	0.78	0.94
Other Operating Expenses	0.98	0.98		0.92	0.92	0.92	1.0	0.91	0.59	0.44	0.98	0.93	0.64	1.0	0.11	0.99	0.55	0.93	-0.02	0.09	0.7	0.57	0.7	0.82	0.91
Operating Income	0.97	0.97	0.92		0.98	0.98	0.9	0.96	0.67	0.44	0.96	1.0	0.65	0.89	0.02	0.9	0.31	0.96	-0.15	0.2	0.56	0.63	0.57	0.71	0.93
Ebit	0.97	0.98	0.92	0.98		1.0	0.9	0.95	0.66	0.43	0.96	0.98	0.54	0.89	-0.04	0.9	0.33	0.94	0.03	0.17	0.57	0.65	0.58	0.72	0.93
Ebitda	0.97	0.98	0.92	0.98	1.0		0.9	0.95	0.66	0.48	0.96	0.98	0.56	0.89	-0.03	0.91	0.34	0.95	0.03	0.21	0.57	0.65	0.59	0.72	0.93
Total Operating Expenses	0.97	0.97	1.0	0.9	0.9	0.9		0.9	0.58	0.44	0.97	0.91	0.63	1.0	0.13	0.98	0.58	0.91	-0.01	0.08	0.7	0.56	0.71	0.82	0.9
Net Income	0.96	0.95	0.91	0.96	0.95	0.95	0.9		0.46	0.49	0.95	0.97	0.65	0.89	-0.06	0.91	0.33	0.99	-0.12	0.2	0.59	0.42	0.59	0.74	0.89
Income Tax Expense	0.64	0.64	0.59	0.67	0.66	0.66	0.58	0.46		0.3	0.62	0.67	0.48	0.58	0.14	0.56	0.16	0.46	-0.07	0.13	0.45	0.99	0.52	0.53	0.67
Depreciation And Amortization	0.45	0.45	0.44	0.44	0.43	0.48	0.44	0.49	0.3		0.46	0.49	0.58	0.41	0.17	0.52	0.34	0.5	-0.02	0.81	0.35	0.28	0.31	0.41	0.44
Cost Of Revenue	1.0	0.99	0.98	0.96	0.96	0.96	0.97	0.95	0.62	0.46		0.97	0.66	0.97	0.03	0.97	0.45	0.96	-0.07	0.14	0.67	0.6	0.68	0.81	0.94
Income Before Tax	0.98	0.98	0.93	1.0	0.98	0.98	0.91	0.97	0.67	0.49	0.97		0.7	0.9	-0.01	0.92	0.32	0.96	-0.15	0.21	0.62	0.64	0.63	0.77	0.94
Total Other Income Expense Net	0.63	0.63	0.64	0.65	0.54	0.56	0.63	0.65	0.48	0.58	0.66	0.7		0.63	0.05	0.64	0.18	0.66	-0.61	0.31	0.69	0.4	0.7	0.75	0.63
Research Development	0.97	0.96	1.0	0.89	0.89	0.89	1.0	0.89	0.58	0.41	0.97	0.9	0.63		0.12	0.97	0.55	0.9	-0.01	0.05	0.71	0.56	0.71	0.83	0.9
Interest Expense	0.05	0.06	0.11	0.02	-0.04	-0.03	0.13	-0.06	0.14	0.17	0.03	-0.01	0.05	0.12		0.13	0.46	0.0	-0.2	0.26	-0.14	0.1	-0.2	-0.15	0.06
Selling General Administrative	0.97	0.97	0.99	0.9	0.9	0.91	0.98	0.91	0.56	0.52	0.97	0.92	0.64	0.97	0.13		0.64	0.93	-0.02	0.16	0.68	0.54	0.68	0.81	0.88
Extraordinary Items	0.45	0.45	0.55	0.31	0.33	0.34	0.58	0.33	0.16	0.34	0.45	0.32	0.18	0.55	0.46	0.64		0.42	0.17	0.11	0.3	0.16	0.31	0.36	0.33
Net Income From Continuing Ops	0.96	0.96	0.93	0.96	0.94	0.95	0.91	0.99	0.46	0.5	0.96	0.96	0.66	0.9	0.0	0.93	0.42		-0.13	0.22	0.59	0.42	0.58	0.73	0.89
Non Recurring	-0.04	-0.04	-0.02	-0.15	0.03	0.03	-0.01	-0.12	-0.07	-0.02	-0.07	-0.15	-0.61	-0.01	-0.2	-0.02	0.17	-0.13		-0.15	-0.04	0.06	-0.04	-0.05	-0.06
Non Operating Income Net Other	0.14	0.14	0.09	0.2	0.17	0.21	0.08	0.2	0.13	0.81	0.14	0.21	0.31	0.05	0.26	0.16	0.11	0.22	-0.15		-0.16	0.11	-0.23	-0.11	0.18
Discontinued Operations	0.65	0.64	0.7	0.56	0.57	0.57	0.7	0.59	0.45	0.35	0.67	0.62	0.69	0.71	-0.14	0.68	0.3	0.59	-0.04	-0.16		0.44	0.93	0.93	0.7
Tax Provision	0.61	0.62	0.57	0.63	0.65	0.65	0.56	0.42	0.99	0.28	0.6	0.64	0.4	0.56	0.1	0.54	0.16	0.42	0.06	0.11	0.44		0.51	0.52	0.65
Interest Income	0.66	0.65	0.7	0.57	0.58	0.59	0.71	0.59	0.52	0.31	0.68	0.63	0.7	0.71	-0.2	0.68	0.31	0.58	-0.04	-0.23	0.93	0.51		0.98	0.63
Net Interest Income	0.79	0.78	0.82	0.71	0.72	0.72	0.82	0.74	0.53	0.41	0.81	0.77	0.75	0.83	-0.15	0.81	0.36	0.73	-0.05	-0.11	0.93	0.52	0.98		0.75
Reconciled Depreciation	0.94	0.94	0.91	0.93	0.93	0.93	0.9	0.89	0.67	0.44	0.94	0.94	0.63	0.9	0.06	0.88	0.33	0.89	-0.06	0.18	0.7	0.65	0.63	0.75

Click cells to compare fundamentals

Vertex Pharmaceuticals Account Relationship Matchups

Vertex Pharmaceuticals income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Revenue	4.2B	6.2B	7.6B	8.9B	9.8B	10.3B
Gross Profit	3.6B	5.5B	6.7B	7.9B	8.6B	9.0B
Operating Income	1.2B	2.9B	2.8B	4.3B	3.8B	3.9B
Ebit	1.2B	2.9B	2.8B	4.3B	3.8B	3.9B
Ebitda	1.5B	3.2B	2.8B	4.3B	3.9B	4.1B
Net Income	1.2B	2.7B	2.3B	3.3B	3.6B	3.8B
Income Tax Expense	218.1M	405.2M	388.3M	910.4M	760.2M	798.2M
Cost Of Revenue	547.8M	736.3M	904.2M	1.1B	1.3B	1.3B
Income Before Tax	1.4B	3.1B	2.7B	4.2B	4.4B	4.6B
Research Development	1.8B	1.8B	3.1B	2.5B	3.7B	3.9B
Interest Expense	58.5M	58.2M	61.5M	54.8M	44.1M	28.9M
Tax Provision	218.1M	405.2M	388.3M	910.4M	760.2M	798.2M
Interest Income	63.7M	22.2M	4.9M	144.6M	614.7M	645.4M
Net Interest Income	5.2M	(35.9M)	(56.6M)	89.8M	570.6M	599.1M

Vertex Pharmaceuticals Investors Sentiment

The influence of Vertex Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Vertex. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Vertex Pharmaceuticals' public news can be used to forecast risks associated with an investment in Vertex. The trend in average sentiment can be used to explain how an investor holding Vertex can time the market purely based on public headlines and social activities around Vertex Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Vertex Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Vertex Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Vertex Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Vertex Pharmaceuticals.

Vertex Pharmaceuticals Implied Volatility

36.94

Vertex Pharmaceuticals' implied volatility exposes the market's sentiment of Vertex Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Vertex Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Vertex Pharmaceuticals stock will not fluctuate a lot when Vertex Pharmaceuticals' options are near their expiration.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vertex Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vertex Pharmaceuticals' short interest history, or implied volatility extrapolated from Vertex Pharmaceuticals options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

S	SentinelOne
GM	General Motors
V	Visa Class A

When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:

How To Invest In Vertex

Details

Is Vertex Stock a good investment?

Details

What is Vertex Pharmaceuticals' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Vertex Pharmaceuticals Valuation and Vertex Pharmaceuticals Correlation analysis.

For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Stocks Directory Find actively traded stocks across global markets
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio

Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.181

Earnings Share

13.91

Revenue Per Share

38.297

Quarterly Revenue Growth

0.093

Return On Assets

0.1317

The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vertex Income Statement Research

Vertex Pharmaceuticals income statement Correlations

Vertex Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vertex Pharmaceuticals income statement Accounts

Vertex Pharmaceuticals Investors Sentiment

Vertex Pharmaceuticals Implied Volatility

Also Currently Popular

Complementary Tools for Vertex Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Research Development	+ 1.0	Other Operating Expenses
Income Before Tax	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit

Non Recurring	- 0.61	Total Other Income Expense Net
Interest Income	- 0.23	Non Operating Income Net Other
Interest Income	- 0.2	Interest Expense
Non Recurring	- 0.2	Interest Expense
Discontinued Operations	- 0.16	Non Operating Income Net Other
Non Operating Income Net Other	- 0.15	Non Recurring